These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
490 related articles for article (PubMed ID: 27864123)
1. PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases. Wang LL; Hao S; Zhang S; Guo LJ; Hu CY; Zhang G; Gao B; Zhao JJ; Jiang Y; Tian WG; Wang J; Luo DL Hum Pathol; 2017 Mar; 61():49-57. PubMed ID: 27864123 [TBL] [Abstract][Full Text] [Related]
2. Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma. Capodanno A; Camerini A; Orlandini C; Baldini E; Resta ML; Bevilacqua G; Collecchi P Hum Pathol; 2009 Oct; 40(10):1408-17. PubMed ID: 19428048 [TBL] [Abstract][Full Text] [Related]
3. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis. Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946 [TBL] [Abstract][Full Text] [Related]
4. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression]. Liu C; Zhou S; Ke CS; Li NP; Wu RL Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847 [TBL] [Abstract][Full Text] [Related]
5. PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer. Duman BB; Sahin B; Acikalin A; Ergin M; Zorludemir S J BUON; 2013; 18(1):44-50. PubMed ID: 23613387 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis. Tang JM; He QY; Guo RX; Chang XJ Lung Cancer; 2006 Feb; 51(2):181-91. PubMed ID: 16324768 [TBL] [Abstract][Full Text] [Related]
7. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer. Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746 [TBL] [Abstract][Full Text] [Related]
8. mRNA expression of programmed cell death ligand 1 and components of the phosphatidylinositol 3-kinase/AKT/phosphatase and tensin homolog pathway in epidermal growth factor receptor mutation-positive lung adenocarcinoma. Han K; Zhang Y J Cancer Res Ther; 2019; 15(4):914-920. PubMed ID: 31436252 [TBL] [Abstract][Full Text] [Related]
9. Activation of PI3K is associated with reduced survival in renal cell carcinoma. Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247 [TBL] [Abstract][Full Text] [Related]
10. TNM classification and the need for revision of pN3a breast cancer. van Nijnatten TJA; Moossdorff M; de Munck L; Goorts B; Vane MLG; Keymeulen KBMI; Beets-Tan RGH; Lobbes MBI; Smidt ML Eur J Cancer; 2017 Jul; 79():23-30. PubMed ID: 28458119 [TBL] [Abstract][Full Text] [Related]
11. Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma. Zhu C; Wei J; Tian X; Li Y; Li X Int J Clin Exp Pathol; 2015; 8(10):12668-77. PubMed ID: 26722456 [TBL] [Abstract][Full Text] [Related]
12. Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years). Zhang ZQ; Han YZ; Nian Q; Chen G; Cui SQ; Wang XY PLoS One; 2015; 10(12):e0144376. PubMed ID: 26656588 [TBL] [Abstract][Full Text] [Related]
13. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer. Deng H; Wu RL; Zhou HY; Huang X; Chen Y; Liu LJ World J Gastroenterol; 2006 Feb; 12(7):1013-7. PubMed ID: 16534839 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN. Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551 [TBL] [Abstract][Full Text] [Related]
15. PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT. Liu X; Chen Q; Hu XG; Zhang XC; Fu TW; Liu Q; Liang Y; Zhao XL; Zhang X; Ping YF; Bian XW Tumour Biol; 2016 Oct; 37(10):13479-13487. PubMed ID: 27465552 [TBL] [Abstract][Full Text] [Related]
16. Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women. Deng L; Chen J; Zhong XR; Luo T; Wang YP; Huang HF; Yin LJ; Qiu Y; Bu H; Lv Q; Zheng H PLoS One; 2015; 10(3):e0120511. PubMed ID: 25816324 [TBL] [Abstract][Full Text] [Related]
17. Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer. Al-Saad S; Donnem T; Al-Shibli K; Persson M; Bremnes RM; Busund LT Anticancer Res; 2009 Oct; 29(10):4175-83. PubMed ID: 19846969 [TBL] [Abstract][Full Text] [Related]
18. Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis. Akita H; Doki Y; Yano M; Miyata H; Miyashiro I; Ohigashi H; Ishikawa O; Nishiyama A; Imaoka S Dis Esophagus; 2009; 22(4):291-7. PubMed ID: 19021686 [TBL] [Abstract][Full Text] [Related]
19. Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype. Chung YR; Kim H; Park SY; Park IA; Jang JJ; Choe JY; Jung YY; Im SA; Moon HG; Lee KH; Suh KJ; Kim TY; Noh DY; Han W; Ryu HS Hum Pathol; 2015 Jul; 46(7):1027-35. PubMed ID: 26004371 [TBL] [Abstract][Full Text] [Related]
20. Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen. Shoman N; Klassen S; McFadden A; Bickis MG; Torlakovic E; Chibbar R Mod Pathol; 2005 Feb; 18(2):250-9. PubMed ID: 15475931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]